EUVIMEDEUVIMED entdecken
Crossref

Mangiferin is a new potential antimalarial and anticancer drug for targeting serine hydroxymethyltransferase

Somchart Maenpuen, Pitchayathida Mee-Udorn, Chatchadaporn Pinthong, Anan Athipornchai, Kochakorn Phiwkaow, Sarayut Watchasit, Panu Pimviriyakul, Thanyada Rungrotmongkol, Ruchanok Tinikul, Ubolsree Leartsakulpanich, Penchit Chitnumsub

Archives of Biochemistry and Biophysics · 2023

DOI: 10.1016/j.abb.2023.109712 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2023. Verfasst von Somchart Maenpuen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Science, Burapha University, Chonburi, 20131, Thailand. Electronic address: somchart@buu.ac.th. Hauptthemen laut MEDLINE: Antimalarials, Xanthones, Folic Acid Antagonists, Antineoplastic Agents. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Kasetsart University, National Research Council of Thailand, Srinakharinwirot University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mangiferin, a polyphenolic xanthone glycoside found in various botanical sources, including mango (Mangifera indica L.) leaves, can exhibit a variety of bioactivities. Although mangiferin has been reported to inhibit many targets, none of the studies have investigated the inhibition of serine hydroxymethyltransferase (SHMT), an attractive target for antimalarial and anticancer drugs. SHMT, one of the key enzymes in the deoxythymidylate synthesis cycle, catalyzes the reversible conversion of l-serine and (6S)-tetrahydrofolate (THF) into glycine and 5,10-methylene THF. Here, in vitro and in silico studies were used to probe how mangiferin isolated from mango leaves inhibits Plasmodium falciparum and human cytosolic SHMTs. The inhibition kinetics at pH 7.5 revealed that mangiferin is a competitive inhibitor against THF for enzymes from both organisms. Molecular docking and molecular dynamic (MD) simulations demonstrated the inhibitory effects of the deprotonated forms of mangiferin, specifically the C6-O- species and its resonance C9-O- species appearing at pH 7.5, combined with two docked poses, either a xanthone or glucose moiety, placed inside the THF-binding pocket. The MD analysis revealed that both C6-O- and its resonance-stabilized C9-O- species can favorably bind to SHMT in a similar fashion to THF, supporting the THF competitive inhibition of mangiferin. In addition, characterization of the proton dissociation equilibria of isolated mangiferin revealed that only three hydroxy groups of the xanthone moiety, C6-OH, C3-OH, and C7-OH, underwent varying degrees of deprotonation with pKa values of 6.38 ± 0.11, 8.21 ± 0.35, and 12.37 ± 0.30, respectively, while C1-OH remained protonated. Altogether, our findings demonstrate a new bioactivity of mangiferin and provide the basis for the future development of mangiferin as a potent antimalarial and anticancer drug.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsXanthonesFolic Acid AntagonistsAntineoplastic AgentsHumansGlycine HydroxymethyltransferaseMolecular Docking SimulationSerine

Stichwörter der Autor:innen

Mangifera indica L.MangiferinPyridoxal-5′-phosphate enzymesSHMT inhibitorSerine hydroxymethyltransferase (SHMT)

Substanzen

AntimalarialsGlycine HydroxymethyltransferasemangiferinXanthonesFolic Acid AntagonistsAntineoplastic AgentsSerine

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Science, Burapha University, Chonburi, 20131, Thailand. Electronic address: somchart@buu.ac.th.
  • National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), 113 Thailand Science Park, Phahonyothin road, Khlong Nueng, Khlong Luang, Pathum Thani, 121…
  • Department of Chemistry, Faculty of Science, Srinakharinwirot University, Bangkok, 10110, Thailand.
  • The Research Unit in Synthetic Compounds and Synthetic Analogues from Natural Product for Drug Discovery, Center of Excellence for Innovation in Chemistry and Department of Chemistry, Faculty of Science, Burapha Univers…
  • Department of Biochemistry, Faculty of Science, Burapha University, Chonburi, 20131, Thailand.
  • Nuclear Magnetic Resonance Spectroscopic Laboratory, Science Innovation Facility, Faculty of Science, Burapha University, Chonburi, 20131, Thailand.

Förderung

  • Kasetsart University
  • National Research Council of Thailand
  • Srinakharinwirot University
  • Ministry of Higher Education, Science, Research and Innovation, Thailand
  • Thailand Science Research and Innovation

Zitieren

APA

Maenpuen, S., Mee-Udorn, P., Pinthong, C., Athipornchai, A., Phiwkaow, K., Watchasit, S., Pimviriyakul, P., Rungrotmongkol, T., Tinikul, R., Leartsakulpanich, U., & Chitnumsub, P. (2023). Mangiferin is a new potential antimalarial and anticancer drug for targeting serine hydroxymethyltransferase. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2023.109712

Vancouver

Maenpuen S, Mee-Udorn P, Pinthong C, Athipornchai A, Phiwkaow K, Watchasit S, et al. Mangiferin is a new potential antimalarial and anticancer drug for targeting serine hydroxymethyltransferase. Archives of Biochemistry and Biophysics. 2023. doi:10.1016/j.abb.2023.109712

BibTeX
@article{Maenpuen2023,
  author = {Maenpuen, Somchart and Mee-Udorn, Pitchayathida and Pinthong, Chatchadaporn and Athipornchai, Anan and Phiwkaow, Kochakorn and Watchasit, Sarayut and Pimviriyakul, Panu and Rungrotmongkol, Thanyada and Tinikul, Ruchanok and Leartsakulpanich, Ubolsree and Chitnumsub, Penchit},
  title = {Mangiferin is a new potential antimalarial and anticancer drug for targeting serine hydroxymethyltransferase},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2023},
  doi = {10.1016/j.abb.2023.109712}
}
Kostenlos starten →